Ultrasound to Evaluate Acute Kidney Injury

Launched by SOUTHEAST UNIVERSITY, CHINA · Feb 2, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how ultrasound can help evaluate acute kidney injury (AKI) in critically ill patients. AKI is a serious condition that can happen in patients who are very sick and can lead to longer hospital stays, higher medical costs, and even a greater risk of death. The trial aims to see if using ultrasound and certain kidney injury markers together can help doctors better understand how severe the kidney damage is and what the patient's future might look like.

To be eligible for this trial, participants need to be between 18 and 80 years old and must meet specific criteria for having acute kidney injury. However, people with severe chronic kidney disease, those on regular dialysis, or who have had kidney transplants, among other conditions, cannot participate. If you join the trial, you will be monitored closely with ultrasound and other tests to help assess your kidney health and guide treatment decisions. This study is not yet open for recruitment, but it aims to improve how doctors can predict and manage kidney issues in critically ill patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Meets diagnostic criteria for AKI (according to KDIGO guidelines); Age ≥ 18 years and ≤ 80 years
• Exclusion Criteria:
• • Chronic kidney disease stage IV-V, maintenance hemodialysis; Kidney tumors; History of kidney transplantation; Nephrectomy; Pregnancy; Arrhythmias that affect the measurement of renal ultrasound.